RankAlpha logo
Back to Rankings

AGMB

AgomAb TherapeuticsD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
9
U.S. public peers
Grade Position
Below peers
vs peer average
AGMB vs peer average
32/100
AGMB vs. peer average (D vs. C)
Grade spread
A 2 · B 1 · C 3 · D 2 · F 1
Graded peers loaded
Coverage
9 graded
100% of tracked

Peer overview

CBIO is the first available peer comparator.

Similarly sized same-sector candidate in the packet; no direct indication or asset overlap was verified, so it is only a loose risk and valuation reference.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerCBIOCrescent Biopharma
AGMB
AgomAb Therapeutics
CBIO
Crescent Biopharma
Grade
D
D
Momentum
70
73
Value
46
41
Sentiment
52
55
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive

Grade position vs CBIO

AGMB / CBIO
Grade Position
Below peers
AGMB vs. peer average (D vs. C)
32/100
Momentum
70
CBIO
Value
46
AGMB
Sentiment
52
CBIO

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs AGMB
1
CBIO
CBIO
D
40/100
Even
2
CRMD
CRMD
A
100/100
-3
3
VALN
Valneva SE ADR
D
40/100
Even
4
SLN
Silence Therapeutics PLC ADR
F
20/100
+1
5
ZVRA
Zevra Therapeutics Inc Common
C
60/100
-1
CBIO is the first peer returned for this comparison set.